Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension / 中华男科学杂志
National Journal of Andrology
;
(12): 830-834, 2007.
Artículo
en Chino
| WPRIM
| ID: wpr-232052
ABSTRACT
The epidemiological survey shows that primary hypertension is one of the independent risk factors in the development and the progress of BPH, 25 percent of old male patients aged 60 or more suffer from the two diseases at the same time, which grievously affects their quality of life. There is little literature about the appropriate therapeutic regimen of BPH associated hypertension. The article reviews the progress in the studies of alpha1-adrenoceptor blocker for BPH associated hypertension, and explores the main problems facing us and ventures the prospects for the development in this field.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Hiperplasia Prostática
/
Prazosina
/
Antagonistas Adrenérgicos alfa
/
Usos Terapéuticos
/
Quimioterapia
/
Antagonistas de Receptores Adrenérgicos alfa 1
/
Hipertensión
Límite:
Anciano
/
Aged80
/
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS